---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-104667"
form_type: "8-K"
ticker: "BCLI"
cik: "0001137883"
company_name: "BRAINSTORM CELL THERAPEUTICS INC."
filed_at: "2024-10-01T23:59:59+00:00"
generated_at: "2026-05-30T23:01:00.131321+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Brainstorm Cell publishes corporate presentation; no material new facts disclosed

## Summary
- Company released a corporate presentation on October 1, 2024, furnished as Exhibit 99.1.
- Presentation will be available on the investor relations section of the company's website.
- Filing excerpt does not contain specific financial or operational details; content of slide not fully provided.

## SEC filing metadata
- accession: 0001104659-24-104667
- form_type: 8-K
- ticker: BCLI
- cik: 0001137883
- company_name: BRAINSTORM CELL THERAPEUTICS INC.
- filed_at: 2024-10-01T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1137883/000110465924104667/0001104659-24-104667-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1137883/000110465924104667/tm2425286d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-104667
- JSON: https://secwatch.observer/filing/0001104659-24-104667.json
- Plain text: https://secwatch.observer/filing/0001104659-24-104667.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.